Medical Exercise Inc. Files Q2 2025 10-Q
| Field | Detail |
|---|---|
| Company | Medical Exercise Inc. |
| Form Type | 10-Q |
| Filed Date | Aug 19, 2025 |
| Risk Level | low |
| Pages | 15 |
| Reading Time | 18 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, quarterly-report, company-information
TL;DR
MEDX filed its 10-Q for Q2 2025. Check financials.
AI Summary
Medical Exercise Inc. filed its 10-Q for the quarterly period ended June 30, 2025. The company, formerly known as MEDX BACK PAIN CLINICS INC. until November 15, 2023, is incorporated in Florida and headquartered in North Palm Beach. The filing details its financial performance and operational status for the specified quarter.
Why It Matters
This filing provides investors and stakeholders with an update on Medical Exercise Inc.'s financial health and operational progress during the second quarter of 2025.
Risk Assessment
Risk Level: low — This is a routine quarterly filing providing standard financial information.
Key Players & Entities
- MEDICAL EXERCISE INC. (company) — Registrant
- MEDX BACK PAIN CLINICS INC. (company) — Former company name
- 20250630 (date) — Quarterly period end date
- 20231115 (date) — Date of former company name change
- Florida (location) — State of incorporation
- North Palm Beach (location) — Principal executive offices city
FAQ
What is the exact period covered by this 10-Q filing?
This 10-Q filing is for the quarterly period ended June 30, 2025.
What was Medical Exercise Inc. previously known as?
Medical Exercise Inc. was formerly known as MEDX BACK PAIN CLINICS INC.
When did the company change its name?
The company's name change from MEDX BACK PAIN CLINICS INC. to MEDICAL EXERCISE INC. occurred on November 15, 2023.
In which state is Medical Exercise Inc. incorporated?
Medical Exercise Inc. is incorporated in Florida.
What is the principal executive office address of Medical Exercise Inc.?
The principal executive offices are located at 11951 US-1, Suite 105, North Palm Beach, FL 33408.
Filing Stats: 4,603 words · 18 min read · ~15 pages · Grade level 15.4 · Accepted 2025-08-19 15:01:32
Key Financial Figures
- $0.001 — g) of the Act: Common Stock, par value $0.001 per share Indicate by check mark if th
Filing Documents
- ea0252889-10q_medical.htm (10-Q) — 314KB
- ea025288901ex31-1_medical.htm (EX-31.1) — 9KB
- ea025288901ex32-1_medical.htm (EX-32.1) — 4KB
- 0001213900-25-078440.txt ( ) — 2706KB
- ck0002001249-20250630.xsd (EX-101.SCH) — 28KB
- ck0002001249-20250630_cal.xml (EX-101.CAL) — 26KB
- ck0002001249-20250630_def.xml (EX-101.DEF) — 131KB
- ck0002001249-20250630_lab.xml (EX-101.LAB) — 229KB
- ck0002001249-20250630_pre.xml (EX-101.PRE) — 141KB
- ea0252889-10q_medical_htm.xml (XML) — 180KB
– Financial Information
PART I – Financial Information Item 1.
Financial Statements
Financial Statements F-1 Balance Sheets as at June 30, 2025 (unaudited) and March 31, 2025 F-2 2024 (unaudited) F-3 ended June 30, 2025 and 2024 (unaudited) F-4 2024 (unaudited) F-5 Notes to Unaudited Financial Statements F-6 Item 2.
Management's Discussion and Analysis of Financial Condition and Results of Operations
Management's Discussion and Analysis of Financial Condition and Results of Operations 2 Item 3.
Quantitative and Qualitative Disclosures About Market Risk
Quantitative and Qualitative Disclosures About Market Risk 4 Item 4.
Controls and Procedures
Controls and Procedures 4
– Other Information
PART II – Other Information Item 1.
Legal Proceedings
Legal Proceedings 7 Item 1A.
Risk Factors
Risk Factors 7 Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 7 Item 3. Defaults Upon Senior Securities 7 Item 4. Mine Safety Disclosures 7 Item 5. Other Information 7 Item 6. Exhibits 7
– FINANCIAL INFORMATION
PART I – FINANCIAL INFORMATION
Financial Statements
Item 1. Financial Statements MEDICAL EXERCISE INC.
FINANCIAL STATEMENTS
FINANCIAL STATEMENTS Page Balance Sheets as of June 30, 2025 (Unaudited) and March 31, 2025 F-2 F-3 F-4 F-5 Condensed Notes to Financial Statements (Unaudited) F-6 F-1 MEDICAL EXERCISE INC. BALANCE SHEETS June 30, March 31, 2025 2025 (Unaudited) Assets Current assets: Cash $ 3,791 $ 450 Total current assets 3,791 450 Property and equipment, net 57,629 59,903 Intangible assets, net 5,201 4,908 Total assets $ 66,621 $ 65,261 Liabilities and Stockholders' Deficit Current liabilities: Accounts payable and accrued expenses $ 33,185 $ 46,358 Advances payable - related parties 153,872 79,548 Contract liabilities 5,929 5,929 Sales tax payable 725 725 Total current liabilities 193,711 132,560 Commitments and contingencies - See Note 7 Stockholders' deficit: Common stock, no par value; 100,000,000 shares authorized; 12,327,000 and 12,222,000 shares issued and outstanding, respectively 422,700 412,200 Subscription receivable ( 5,000 shares) ( 500 ) ( 500 ) Accumulated deficit ( 549,290 ) ( 478,999 ) Total stockholders' deficit ( 127,090 ) ( 67,299 ) Total liabilities and stockholders' deficit $ 66,621 $ 65,261 The accompanying condensed notes are an integral part of the unaudited financial statements. F-2 MEDICAL EXERCISE INC. (Unaudited) For the Three For the Three Months Ended Months Ended June 30, June 30, 2025 2024 Revenues $ - $ 1,294 Cost of revenues - 445 Operating profit - 849 Operating expenses: Compensation expense 5,000 25,650 Advertising 1,032 5,396 Depreciation and amortization 2,881 2,868 Impairment of property an